IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KEVIN STEIN

Allopathic & Osteopathic Physicians Dermatology

NPI
1730221037
CMS profile
1209835
Location
WINSTON SALEM, NC

General Payments · PY2018–2024

$11,733.58

  • Reported across 301 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$839.73

53 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Dermatology NC All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $781.47 51
Education $58.26 2

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
E.R. Squibb & Sons, L.L.C. $185.56 21
GENZYME CORPORATION $107.50 5
ABBVIE INC. $93.01 5
Dermavant Sciences, Inc. $66.53 3
Arcutis Biotherapeutics, Inc. $56.15 3
PFIZER INC. $50.37 3
SUN PHARMACEUTICAL INDUSTRIES INC. $42.99 1
UCB, Inc. $42.65 2
NOVARTIS PHARMACEUTICALS CORPORATION $42.34 2
Lilly USA, LLC $34.73 2
Amgen Inc. $21.51 1
Boehringer Ingelheim Pharmaceuticals, Inc. $21.40 1
Regeneron Healthcare Solutions, Inc. $20.61 1
Galderma Laboratories, L.P. $19.97 1
Janssen Biotech, Inc. $19.23 1
Biofrontera Inc. $15.18 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,486.05 35
PY2019 $3,870.78 44
PY2020 $1,743.49 21
PY2021 $773.43 37
PY2022 $842.21 49
PY2023 $1,177.89 62
PY2024 $839.73 53

Payment records · PY2024 (53)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $13.68 03/28/2024 Food and Beverage Undisputed 01/23/2026 1106158594 CMS
ABBVIE INC. $26.94 05/29/2024 Food and Beverage Undisputed 01/23/2026 1106158596 CMS
ABBVIE INC. $18.28 07/31/2024 Food and Beverage Undisputed 01/23/2026 1106158598 CMS
ABBVIE INC. $14.62 09/06/2024 Food and Beverage Undisputed 01/23/2026 1106158600 CMS
ABBVIE INC. $19.49 10/25/2024 Food and Beverage Undisputed 01/23/2026 1106158602 CMS
Amgen Inc. $21.51 04/26/2024 Food and Beverage Undisputed 01/23/2026 1117391202 CMS
Arcutis Biotherapeutics, Inc. $14.34 03/08/2024 Food and Beverage Undisputed 01/23/2026 1121058063 CMS
Arcutis Biotherapeutics, Inc. $20.72 07/13/2024 Food and Beverage Undisputed 01/23/2026 1121058065 CMS
Arcutis Biotherapeutics, Inc. $21.09 11/01/2024 Food and Beverage Undisputed 01/23/2026 1121058067 CMS
Biofrontera Inc. $15.18 02/02/2024 Food and Beverage Undisputed 01/23/2026 1091116965 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.40 09/13/2024 Food and Beverage Undisputed 01/23/2026 1118131089 CMS
Dermavant Sciences, Inc. $18.35 04/12/2024 Food and Beverage Undisputed 01/23/2026 1127938942 CMS
Dermavant Sciences, Inc. $22.94 05/17/2024 Food and Beverage Undisputed 01/23/2026 1127938946 CMS
Dermavant Sciences, Inc. $25.24 08/09/2024 Food and Beverage Undisputed 01/23/2026 1127938949 CMS
E.R. Squibb & Sons, L.L.C. $5.08 01/11/2024 Food and Beverage Undisputed 01/23/2026 1101589570 CMS
E.R. Squibb & Sons, L.L.C. $7.65 01/11/2024 Food and Beverage Undisputed 01/23/2026 1101589574 CMS
E.R. Squibb & Sons, L.L.C. $7.64 02/07/2024 Food and Beverage Undisputed 01/23/2026 1101589585 CMS
E.R. Squibb & Sons, L.L.C. $7.59 02/19/2024 Food and Beverage Undisputed 01/23/2026 1101589600 CMS
E.R. Squibb & Sons, L.L.C. $4.35 02/19/2024 Food and Beverage Undisputed 01/23/2026 1101589604 CMS
E.R. Squibb & Sons, L.L.C. $5.13 02/19/2024 Food and Beverage Undisputed 01/23/2026 1101589607 CMS
E.R. Squibb & Sons, L.L.C. $12.33 03/06/2024 Food and Beverage Undisputed 01/23/2026 1101589611 CMS
E.R. Squibb & Sons, L.L.C. $10.29 04/23/2024 Food and Beverage Undisputed 01/23/2026 1101589633 CMS
E.R. Squibb & Sons, L.L.C. $17.63 05/01/2024 Food and Beverage Undisputed 01/23/2026 1101589640 CMS
E.R. Squibb & Sons, L.L.C. $5.15 05/09/2024 Food and Beverage Undisputed 01/23/2026 1101589637 CMS
E.R. Squibb & Sons, L.L.C. $8.17 05/21/2024 Food and Beverage Undisputed 01/23/2026 1101589678 CMS
E.R. Squibb & Sons, L.L.C. $5.68 05/21/2024 Food and Beverage Undisputed 01/23/2026 1101589682 CMS
E.R. Squibb & Sons, L.L.C. $7.25 06/13/2024 Food and Beverage Undisputed 01/23/2026 1101589674 CMS
E.R. Squibb & Sons, L.L.C. $15.36 06/14/2024 Food and Beverage Undisputed 01/23/2026 1101589666 CMS
E.R. Squibb & Sons, L.L.C. $10.16 06/14/2024 Food and Beverage Undisputed 01/23/2026 1101589670 CMS
E.R. Squibb & Sons, L.L.C. $12.76 08/07/2024 Food and Beverage Undisputed 01/23/2026 1101589700 CMS
E.R. Squibb & Sons, L.L.C. $9.15 09/12/2024 Food and Beverage Undisputed 01/23/2026 1101589708 CMS
E.R. Squibb & Sons, L.L.C. $12.61 09/20/2024 Food and Beverage Undisputed 01/23/2026 1101589712 CMS
E.R. Squibb & Sons, L.L.C. $7.95 11/04/2024 Food and Beverage Undisputed 01/23/2026 1101589748 CMS
E.R. Squibb & Sons, L.L.C. $11.50 11/06/2024 Food and Beverage Undisputed 01/23/2026 1101589752 CMS
E.R. Squibb & Sons, L.L.C. $2.13 11/06/2024 Food and Beverage Undisputed 01/23/2026 1101589755 CMS
Galderma Laboratories, L.P. $19.97 12/27/2024 Food and Beverage Undisputed 01/23/2026 1145330353 CMS
GENZYME CORPORATION $21.72 04/19/2024 Food and Beverage Undisputed 01/23/2026 1139774839 CMS
GENZYME CORPORATION $17.37 08/16/2024 Food and Beverage Undisputed 01/23/2026 1139774881 CMS
GENZYME CORPORATION $17.99 09/04/2024 Food and Beverage Undisputed 01/23/2026 1139774885 CMS
GENZYME CORPORATION $29.04 10/09/2024 Food and Beverage Undisputed 01/23/2026 1139774899 CMS
GENZYME CORPORATION $21.38 10/30/2024 Food and Beverage Undisputed 01/23/2026 1139774909 CMS
Janssen Biotech, Inc. $19.23 03/21/2024 Food and Beverage Undisputed 01/23/2026 1078332913 CMS
Lilly USA, LLC $17.87 02/16/2024 Food and Beverage Undisputed 01/23/2026 1135134332 CMS
Lilly USA, LLC $16.86 08/30/2024 Food and Beverage Undisputed 01/23/2026 1135131046 CMS
Novartis Pharmaceuticals Corporation $27.87 01/05/2024 Food and Beverage Undisputed 01/23/2026 1087265379 CMS
Novartis Pharmaceuticals Corporation $14.47 07/05/2024 Food and Beverage Undisputed 01/23/2026 1087265415 CMS
PFIZER INC. $18.06 02/23/2024 Food and Beverage Undisputed 01/23/2026 1131151628 CMS
PFIZER INC. $17.04 05/10/2024 Food and Beverage Undisputed 01/23/2026 1131442885 CMS
PFIZER INC. $15.27 07/19/2024 Education Undisputed 01/23/2026 1131606880 CMS
Regeneron Healthcare Solutions, Inc. $20.61 05/31/2024 Food and Beverage Undisputed 01/23/2026 1114194316 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $42.99 07/17/2024 Education Undisputed 01/23/2026 1152169780 CMS
UCB, Inc. $16.03 01/26/2024 Food and Beverage Undisputed 01/23/2026 1143390269 CMS
UCB, Inc. $26.62 08/03/2024 Food and Beverage Undisputed 01/23/2026 1143390273 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.